Title of Oral/Poster Presentation

Addressing Perinatal Mortality

Class

Article

College

Emma Eccles Jones College of Education and Human Services

Department

Kinesiology & Health Sciences

Presentation Type

Oral Presentation

Abstract

Our research presents a proposed public health program which will address and provide activities related to training mental health providers, establish a perinatal-specific mom-baby inpatient treatment unit, and incorporate FDA approved pharmacological treatments alongside standard evidence-based treatment modalities. This evidence-based treatment program will be available near but separate from all inpatient psychiatric treatment facilities (i.e. our target population) as a long-term goal, but our program aims to pilot a program in a single large metropolitan hospital psychiatric ward (i.e. our recipient audience). We will take an innovative approach that requires a local early-adopter to demonstrate its feasibility and value before wide-spread use. Mental health care interventions are needed at all levels of the public health pyramid, but our program will look to intervene at the infrastructure level to ensure that those at the highest risk for self-harm or harm to others receive appropriate care. This type of perinatal specific care is readily available in other countries such as Great Britain and Australia, and a similar innovative program exists at the University of North Carolina Chapel Hill, but no such program exists in Utah. Evidence-based treatment from highly qualified and trained providers and inpatient treatment specific to the unique needs of women in the perinatal period is necessary to reduce morbidity and mortality in this population.

Location

Room 208

Start Date

4-10-2019 1:30 PM

End Date

4-10-2019 2:45 PM

Share

COinS
 
Apr 10th, 1:30 PM Apr 10th, 2:45 PM

Addressing Perinatal Mortality

Room 208

Our research presents a proposed public health program which will address and provide activities related to training mental health providers, establish a perinatal-specific mom-baby inpatient treatment unit, and incorporate FDA approved pharmacological treatments alongside standard evidence-based treatment modalities. This evidence-based treatment program will be available near but separate from all inpatient psychiatric treatment facilities (i.e. our target population) as a long-term goal, but our program aims to pilot a program in a single large metropolitan hospital psychiatric ward (i.e. our recipient audience). We will take an innovative approach that requires a local early-adopter to demonstrate its feasibility and value before wide-spread use. Mental health care interventions are needed at all levels of the public health pyramid, but our program will look to intervene at the infrastructure level to ensure that those at the highest risk for self-harm or harm to others receive appropriate care. This type of perinatal specific care is readily available in other countries such as Great Britain and Australia, and a similar innovative program exists at the University of North Carolina Chapel Hill, but no such program exists in Utah. Evidence-based treatment from highly qualified and trained providers and inpatient treatment specific to the unique needs of women in the perinatal period is necessary to reduce morbidity and mortality in this population.